Clinical Trial Update: TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke [NA]

View source ↗

Summary

The clinical trial evaluated TSK (Tryptophan - Serotonin - Kynurenine) biomarkers in stroke, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Snippet

Sponsor: Versailles Hospital | Conditions: Cerebral Infarction | NA | Status: COMPLETED